Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Researchers Find Risk Markers for… >
Researchers Find Risk Markers for Erectile Dysfunction Following Radiation in Prostate Cancer

Published: September 27, 2012.
By The Mount Sinai Hospital / Mount Sinai School of Medicine
http://www.mountsinai.org

In the first study of its kind, a research team led by Mount Sinai School of Medicine and Albert Einstein College of Medicine of Yeshiva University discovered 12 genetic markers associated with the development of erectile dysfunction (ED) in prostate cancer patients who were treated with radiation. The findings, to be published online September 27, 2012, in advance of the October 1, 2012 print issue in the International Journal of Radiation Oncology• Biology• Physics, the official scientific journal of the American Society for Radiation Oncology, are an important step towards helping clinicians determine the best course of treatment for prostate cancer patients and may lead to the development of therapies that alleviate side effects.

The main treatments for prostate cancer – surgery, brachytherapy (seed implants) and external beam radiation therapy – are all very effective at curing prostate cancer. Unfortunately, each treatment places patients at risk for ED. According to the National Cancer Institute, the prevalence of erectile dysfunction following external beam radiation for prostate cancer ranges from 65 percent to 85 percent. The Prostate Cancer Foundation estimates prevalence of ED following seed therapy at 25 to 50 percent. Many men will be able to regain their potency with time and treatments, but doctors would like to identify which men may be more likely to develop this side effect.

In the first large scale Genome-Wide Association Study to identify single nucleotide polymorphisms (SNPs) associated with susceptibility for the development of erectile dysfunction following radiotherapy for prostate cancer, researchers conducted a two-part study, first, to discover the candidate genetic markers of side effect risk, and second, to confirm which of those markers are replicated in a second group of patients. In the first group of prostate cancer patients, which included 132 men who developed erectile dysfunction after radiotherapy and 103 men similarly treated who did not develop erectile dysfunction, they found a set of genetic markers associated with erectile dysfunction. In the second part of the study, which examined 128 patients who developed erectile dysfunction after radiotherapy and 102 who did not, researchers confirmed that 12 SNPs were associated with erectile dysfunction.

"Thankfully, current treatments for prostate cancer offer excellent rates of long-term survival, so patients and their physicians have a choice about which treatment path to take," said Barry Rosenstein, PhD, Professor of Radiation Oncology, Mount Sinai School of Medicine. "However, the risk of developing erectile dysfunction after radiation treatment is highly variable, suggesting there may be a genetic component to determining that risk. Our study confirms that specific markers make certain patients more susceptible to this side effect."

Patients in the study cohort were given one of three treatments: internal radiotherapy, known as brachytherapy; brachytherapy plus external beam radiation; or external beam radiation alone. They were followed for an average length of nearly four years to determine level of sexual function after treatment.

Interestingly, the 12 SNPs identified in this study were located near genes that seem to be related to erectile function rather than related to radiation response. The researchers conclude that these SNPs may affect genes that sensitize a patient to developing erectile dysfunction when exposed to radiation during therapy.

"Prostate cancer screening and treatment are undergoing major shifts," said Harry Ostrer, MD, Professor of Pathology and Genetics at Albert Einstein College of Medicine and Director of Genetic and Genomic Testing at Montefiore Medical Center and co-principal investigator of the study. "This is part of our ongoing effort to identify men at highest risk for disease, identify the aggressive tumors that would be responsive to therapy, and to improve quality of life for men with indolent prostate cancers who might benefit from active surveillance, rather than therapy."

The authors indicate that examination of a large, independent cohort of similarly treated patients will be necessary to definitively determine which SNPs to include as part of a clinically useful predictive test to identify which men are at greatest risk for developing erectile dysfunction following prostate cancer radiotherapy. The researchers are also evaluating the impact of radiation treatment on urinary complications and proctitis, the inflammation of the rectum.


Show Reference »


Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


 
All comments are reviewed before being posted. We cannot accept messages that refer a product, or web site.If you are looking for a response to a question please use our another feedback page.
Related »

Cancer 
10/25/10 
Adding Radiation to Hormone Therapy for Prostate Cancer Treatment Will Increase Survival Chances
By American Society for Radiation Oncology
Prostate cancer patients who are treated with a combination of hormone therapy and radiation have a substantially improved chance of survival compared to patients who do not receive radiation, …
Heart 
7/26/11 
Hormone Therapy May Be Hazardous for Men with Heart Conditions
By American Society for Radiation Oncology
Fairfax, Va., July 26, 2011 – Adding hormone therapy to radiation therapy has been proven in randomized clinical trials to improve overall survival for men with intermediate- and high-risk …
Radiation 
9/27/12 
Predicting Erectile Dysfunction from Prostate Cancer Treatment
By American Society for Radiation Oncology
Researchers have identified 12 DNA sequences that may help doctors determine which men will suffer from erectile dysfunction (ED) following radiation therapy for prostate cancer. Identifying these patients in …
Cancer 
2/1/12 
Research from the 2012 Genitourinary Cancers Symposium Highlights New Treatments, Compares Existing Therapies for Prostate Cancer
By American Society of Clinical Oncology
Research on promising new therapies and data on the relative benefits of established treatments for prostate cancer were released today, in advance of the fourth annual Genitourinary Cancers Symposium, …
Radiation 
10/22/10 
Practice-changing Studies on How Oncologists Treat Cancer to Be Presented at ASTRO Annual Meeting
By American Society for Radiation Oncology
The following are highlights of new cancer research being released at the American Society for Radiation Oncology's (ASTRO) 52nd Annual Meeting to be held October 31 through November 4, …
Treatment 
1/4/13 
How Prostate Cancer Therapies Compare by Cost And Effectiveness
By University of California - San Francisco
The most comprehensive retrospective study ever conducted comparing how the major types of prostate cancer treatments stack up to each other in terms of saving lives and cost effectiveness …
Treatment 
8/15/12 
Urology-owned Radiation Oncology Self-referral Can Increase Patients' Travel Distance for Treatment
By American Society for Radiation Oncology
Men with prostate cancer in Texas may be driving more than three times farther than needed to obtain radiation oncology treatments for their cancer when treated at a urology-owned …
Radiation 
6/1/12 
Antioxidant Beta-carotene Use Safe During Radiation Treatment for Prostate Cancer
By American Society for Radiation Oncology
Despite past safety concerns, the antioxidant supplement beta-carotene, is safe to use during radiation therapy treatments for prostate cancer and does not increase the risk of prostate cancer death …
Cancer 
5/30/14 
Radiation for Prostate Cancer Linked to Secondary Cancers, Study Finds
By University of Michigan Health System
ANN ARBOR, Mich. — Among men treated for prostate cancer, those who received radiation therapy were more likely to develop bladder or rectal cancer, according to a new study …
Cancer 
4/1/12 
Oxygen in Tumors Predicts Prostate Cancer Recurrence
By University Health Network
Low oxygen levels in tumors can be used to predict cancer recurrence in men with intermediate-risk prostate cancer even before they receive radiation therapy. The clinical research, led …
Prostate 
5/10/11 
Sensitizing Prostate Cancer to Radiotherapy
By Journal of Clinical Investigation
Men with prostate cancer whose disease has spread locally from inside the prostate to immediately outside it are primarily treated with radiation therapy. However, disease recurs in approximately half …
Therapy 
11/3/11 
Radiation Plus Hormone Therapy Greatly Improves Survival
By University Health Network
Men with locally advanced or high-risk prostate cancer who receive combined radiation and hormone therapy live longer and are less likely to die from their disease, shows clinical research …
Cancer 
10/25/10 
Aspirin Use Associated with Lower Risk of Cancer Death for Men with Prostate Cancer
By American Society for Radiation Oncology
Men with prostate cancer who take anticoagulants like aspirin in addition to radiation therapy or surgery may be able to cut their risk of dying of the disease by …
Higher 
6/26/12 
★★★ 
Novel Radiation Therapy Safely Treats Prostate Cancer And Lowers the Risk of Recurrence
By Virginia Commonwealth University
Richmond, Va. (June 22, 2012) – A recent Phase I/II clinical trial has shown that a new combination of radiation therapies developed at Virginia Commonwealth University Massey Cancer Center …
Surgery 
3/15/13 
Surgery Is Superior to Radiotherapy in Men with Localized PCa, Says Prize-winning Swedish Study
By European Association of Urology
Arnhem, 11 March 2013 - Surgery offers better survival benefit for men with localised prostate cancer, according to a large observational study, conducted by a group of researchers in …
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile  |  Japanese Edition
All contents are copyright of their owners except U.S. Government works. U.S. Government works are assumed to be in the public domain unless otherwise noted. Everything else copyright ScienceNewsline.